Home > Items where Subject is "MP-MR Policy, planning, economics, work and social services > Programme planning, implementation, and evaluation > Programme and budget analysis (cost benefit)"

up arrow imageUp a level
Export as
Group by: Item Type | No Grouping
Number of items at this level: 56.


Millar, Sean (2022) Cost-effectiveness of mass screening for hepatitis C virus in Irish prisons. Drugnet Ireland , Issue 83, Winter 2022 , p. 15.

Saygın Avşar, Tuba and Jackson, Louise and Barton, Pelham and Jones, Matthew and McLeod, Hugh (2022) Towards optimum smoking cessation interventions during pregnancy: a household model to explore cost-effectiveness. Addiction , 17 , (10) , pp. 2707-2719.

Roscoe, Suzie and Pryce, Robert and Buykx, Penny and Gavens, Lucy and Meier, Petra S (2022) Is disinvestment from alcohol and drug treatment services associated with treatment access, completions and related harm? An analysis of English expenditure and outcomes data. Drug and Alcohol Review , 41 , (1) , pp. 54-61.

Ward, Zoe and Mafirakureva, Nyashadzaishe and Stone, Jack and Keevans, Mary and Betts-Symonds, Graham and Crowley, Desmond and McHugh, Tina and Avramovic, Gordana and Lambert, John S and Vickerman, Peter (2021) Cost-effectiveness of mass screening for Hepatitis C virus among all inmates in an Irish prison. International Journal of Drug Policy , 96 .

Salloum, Ramzi G and D'Angelo, Heather and Theis, Ryan P and Rolland, Betsy and Hohl, Sarah and Pauk, Danielle and LeLaurin, Jennifer H and Asvat, Yasmin and Chen, Li-Shiun and Day, Andrew T and Goldstein, Adam O and Hitsman, Brian and Hudson, Deborah and King, Andrea C and Lam, Cho Y and Lenhoff, Katie and Levinson, Arnold H and Prochaska, Judith and Smieliauskas, Fabrice and Taylor, Kathryn and Thomas, Janet and Tindle, Hilary and Tong, Elisa and White, Justin S and Vogel, W Bruce and Warren, Graham W and Fiore, Michael (2021) Mixed-methods economic evaluation of the implementation of tobacco treatment programs in National Cancer Institute-designated cancer centers. Implementation Science Communications , 2 , (1) , p. 41.

Drouin, Olivier and Sato, Ryoko and Drehmer, Jeremy E and Nabi-Burza, Emara and Hipple Walters, Bethany and Winickoff, Jonathan P and Levy, Douglas E (2021) Cost-effectiveness of a smoking cessation intervention for parents in pediatric primary care. JAMA Network Open , 4 , (4) , e213927.

Bowser, Diana M and Henry, Brandy F and McCollister, Kathryn E (2021) Cost analysis in implementation studies of evidence-based practices for mental health and substance use disorders: a systematic review. Implementation Science , 16 , (26) .

Leão, Teresa and Perelman, Julian and Clancy, Luke and Hoffmann, Laura and Kinnunen, Jaana M and Mélard, Nora and Nuyts, Paulien A W and Richter, Matthias and Rimpelä, Arja and Lorant, Vincent and Kunst, Anton E (2020) Cost of youth tobacco-control policies in seven European countries. European Journal of Public Health , 30 , (2) , pp. 374-379.

Agus, Ashley and McKay, Michael and Cole, Jonathan and Doherty, Paul and Foxcroft, David and Harvey, Séamus and Murphy, Lynn and Percy, Andrew and Sumnall, Harry (2019) Cost-effectiveness of a combined classroom curriculum and parental intervention: economic evaluation of data from the Steps Towards Alcohol Misuse Prevention Programme cluster randomised controlled trial. BMJ Open , 9 , (7) , e027951.

Ahern, Susan and Burke, Lee Ann and McElroy, Brendan and Corcoran, Paul and McMahon, Elaine M and Keeley, Helen and Carli, Vladimir and Wasserman, Camilla and Hoven, Christina W and Sarchiapone, Marco and Apter, Alan and Balazs, Judit A and Banzer, Raphaela and Bobes, Julio and Brunner, Romuald and Cosman, Doina and Haring, Christian and Kaess, Michael and Kahn, Jean Pierre and Kereszteny, Agnes (2018) A cost-effectiveness analysis of school-based suicide prevention programmes. European Child & Adolescent Psychiatry , 27 , (10) , pp. 1295-1304.

Drug and Alcohol Findings. (2017) Family therapies best for substance using teenagers. Drug and Alcohol Findings Review Analysis , (5 May 2017) .

Irwin, Amos and Jozaghi, Ehsan and Bluthenthal, Ricky N and Kral, Alex H (2017) A cost-benefit analysis of a potential supervised injection facility in San Francisco, California, USA.. Journal of Drug Issues , 47 , (2) .

Angus, Colin and Thomas, Chloe and Anderson, Peter and Meier, Petra S and Brennan, Alan (2017) Estimating the cost-effectiveness of brief interventions for heavy drinking in primary health care across Europe. European Journal of Public Health , 27 , (2) , pp. 345-351.

Atusingwize, Edwinah and Lewis, Sarah and Langley, Tessa (2015) Economic evaluations of tobacco control mass media campaigns: a systematic review. Tobacco Control , 24 .

Hayhurst, Karen P and Leitner, Maria and Davies, Linda and Flentje, Rachel and Millar, Tim and Jones, Andrew and King, Carlene and Donmall, Micheal and Farrell, Michael and Fazel, Seena and Harris, Rochelle and Hickman, Matthew and Lennox, Charlotte and Mayet, Soraya and Senior, Jane and Shaw, Jennifer (2015) The effectiveness and cost-effectiveness of diversion and aftercare programmes for offenders using class A drugs: a systematic review and economic evaluation. Health Technology Assessment , 19 , (6) .

Chen, YF and Madan, J and Welton, N and Yahaya, I and Aveyard, Paul and Bauld, L and Wang, D and Fry-Smith, A and Munafo, Marcus R (2012) Effectiveness and cost-effectiveness of computer and other electronic aids for smoking cessation: a systematic review and network meta-analysis. Health Technology Assessment , 16 , (38) .

O'Shea, Jacinta and Keenan, Eamon (2004) Harm reduction initiatives for drug users and the general population: what value to society? Irish Psychiatrist , 5 , (3) , pp. 109-110.


World Health Organization Regional Office for Europe. (2022) Integrated brief interventions for noncommunicable disease risk factors in primary care: the manual: BRIEF project. Copenhagen: World Health Organization Regional Office for Europe.

Public Health England. (2021) Parents with alcohol and drug problems: using case studies to estimate the cost-benefit of interventions. London: Gov.UK.

Quality Matters. (2021) A social return on investment analysis on the impact of DIAL House. Dublin: Novas.

UNSW Social Policy Research Centre. (2020) NSW Involuntary Drug and Alcohol Treatment (IDAT) program. Sydney: UNSW Social Policy Research Centre.

Canadian Substance Use Costs and Harms Scientific Working Group. (2020) Canadian substance use costs and harms (2015-2017). Ottawa, Ont.: Canadian Centre on Substance Use and Addiction.

Harm Reduction International. (2020) Making the investment case: cost-effectiveness evidence for harm reduction. London: Harm Reduction International.

Whetton, Steve and Tait, Robert J and Chrzanowska, Agata and Donnelly, Neill and McEntee, Alice and Mukhtar, Aquif and Zahra, Emma and Campbell, Gabrielle and Degenhardt, Louisa and Dey, Tania and Abdul Halim, Suraya and Hall, Wayne and Makate, Marshall and Norman, Richard and Peacock, Amy and Roche, Ann and Allsop, Steve (2020) Quantifying the social costs of pharmaceutical opioid misuse & illicit opioid use to Australia in 2015/16. Perth, WA: National Drug Research Institute, Curtin University.

Ex-Prisoners Recovering from Addiction Working Group. (2019) Blueprints for the treatment and throughcare of prisoners with histories of drug dependence. A report from the ex-prisoners recovering from addiction (EPRA) working group. University of York.

Edge, Rob and Butcher, Robyn (2019) Buprenorphine for opioid use disorders during pregnancy: a review of comparative clinical effectiveness, safety, cost-effectiveness, and guidelines. Ottawa: Canadian Agency for Drugs and Technologies in Health.

Health Information and Quality Authority. (2017) Health technology assessment (HTA) of smoking cessation interventions. Dublin: Health Information and Quality Authority.

Ireland. Department of Health. (2016) Regulatory impact analysis (RIA): Public Health (Alcohol) Bill. Dublin: Department of Health.

Public Health England. (2015) Health matters: smoking and quitting in England. London: Public Health England.

Department of Children and Youth Affairs. (2014) Value for money and policy review of the youth programmes. Dublin: Government Publications.

Canadian Agency for Drugs and Technologies in Health. (2013) Suboxone versus methadone for the treatment of opioid dependence: a review of the clinical and cost-effectiveness. Ottawa: Canadian Agency for Drugs and Technologies in Health.

Frontier Economics. (2011) Specialist drug and alcohol services for young people – a cost benefit analysis. London: Department for Education.

National Treatment Agency for Substance Misuse. (2011) Why invest? How drug treatment and recovery services work for individuals, communities and society. London: National Treatment Agency for Substance Misuse.

Anderson, Peter and Baumberg, Ben (2010) Cost benefit analyses of alcohol policy - a primer. Final report prepared for the project Standardizing Measurement of Alcohol Related Troubles - SMART. Warsaw: Institute of Psychiatry and Neurology.

Domnall, Michael and Jones, Andrew and Davies, Linda and Barnard, Matthew (2009) Summary of key findings from the Drug Treatment Outcomes Research Study (DTORS). Research report 23. London: Home Office.

Probation Service. (2009) Value for money and policy review of the Community Service scheme. Dublin: Department of Justice, Equality & Law Reform.

Davies, Linda and Jones, Andrew and Vamvakas, Georgios and Dubourg, Richard and Donmall, Micheal (2009) The Drug Treatment Outcomes Research study (DTORS): Cost-effectiveness analysis. Research report 25. London: Home Office.

Bywood, Petra and Lunnay, Belinda and Roche, Ann (2008) Effective dissemination: An examination of the costs of implementation strategies for the AOD field. Adelaide: National Centre for Education and Training on Addiction.

Jones, Andrew and Weston, Samantha and Moody, Alison and Millar, Tim and Dollin, Laura and Anderson, Tracy (2007) The drug treatment outcomes research study (DTORS): baseline report. Research report 3. London: Home Office.

National Centre for Pharmacoeconomics. (2007) Economic evaluation of the use of Suboxone for opiate addiction. Dublin: National Centre for Pharmacoeconomics.

Combat Poverty Agency. (2004) Investing in the future: ending child and family poverty. Combat Poverty Agency submission on Budget 2004. Dublin: Combat Poverty Agency.

WHO, UNDCP & EMCDDA. (2000) Evaluation of psychoactive substance use disorder treatment, workbook 5: cost evaluations. WHO, UNDCP & EMCDDA.

Yates, Brian T (1999) Measuring and improving cost, cost-effectiveness, and cost-benefit for substance abuse treatment programs: a manual. Bethesda, MD: National Institute on Drug Abuse, Division of Clinical and Services Research.

Dail Debates

[Oireachtas] Dail Eireann debate. Written answer 636. & 759 - National drugs strategy budget [13556/16]. (31 May 2016)

[Oireachtas] Dail Eireann debate. Written answer 825 - National drugs strategy budget [10276/16]. (17 May 2016)

[Oireachtas] Dail Eireann debate. Written answer 978 - Substance misuse [Cost of alcoholism] [31376/15]. (22 Sep 2015)

[Oireachtas] Dail Eireann debate. Written answers 146 & 147 - Departmental expenditure [Justice] [26481/15, 26482/15]. (01 Jul 2015)

[Oireachtas] Dail Eireann debate. Written answer 196 - National drugs strategy budget [26479/15]. (01 Jul 2015)

[Oireachtas] Dail Eireann debate. Written answer 602 - National Drugs Strategy budget [23386/15]. (16 Jun 2015)

[Oireachtas] Dail Eireann debate. Written answer 545 - Drug treatment programmes [49567/14]. (14 Jan 2015)

[Oireachtas] Dail Eireann debate. Written answer 174 - National drugs strategy budget. [5772/14]. (05 Feb 2014)

[Oireachtas] Dail Eireann debate. Written answer 209 - National Drugs Strategy [Methadone]. [20265/11]. (13 Jul 2011)

[Oireachtas] Committee of Public Accounts. Special report no. 64 of Comptroller and Auditor General: Drug addiction treatment and rehabilitation (resumed). (17 Dec 2009)

Committee on Public Accounts. [Oireachtas] Committee of Public Accounts. Special report no. 64 of Comptroller and Auditor General: Drug addiction treatment and rehabilitation (resumed). (17 Sep 2009)

[Oireachtas] Committee on Public Accounts. Special report no. 64 of Comptroller and Auditor General: Drug addiction treatment and rehabilitation. (09 Jul 2009)

[Oireachtas] Dail Eireann debate. Priority question 51 - National Drugs Strategy [32629/07]. (05 Dec 2007)

This list was generated on Fri Dec 2 04:11:02 2022 GMT.